If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCapital Metals Regulatory News (CMET)

Share Price Information for Capital Metals (CMET)

Share Price is delayed by 15 minutes
Get Live Data
4.75    -0.15 (-3.06%)
Bid:
4.50
Ask:
5.00
Spread: 0.50 (11.111%)
Market Cap: £23.38m
CMET Live PriceLast checked at - London Stock Exchange

Intraday Capital Metals Share Chart

Issue of Equity

5 Feb 2021 07:00

RNS Number : 0789O
Capital Metals PLC
05 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

5 February 2021 

 

CAPITAL METALS plc

("CMET" or the "Company")

Issue of Equity

Capital Metals Plc (AIM: CMET) is a natural resources company focussed on the development of the Eastern Minerals Project in Sri Lanka, one of the highest grade mineral sands projects globally.

The Company announces the issue of 247,891 ordinary shares of 0.2 pence each ("the Shares") to settle the interest component of convertible bonds ("the Convertible Bonds") previously issued by its subsidiary, Capital Metals Limited. The Convertible Bonds were detailed in the Company's admission document published on 23 December 2020 ("Admission Document"). The conversion of interest on the Convertible Bonds to shares was applicable at the completion of the RTO on 13 January 2021 for a deemed value of US$27,888. Following the issue of the Shares, the settlement of the Convertible Bonds has now been completed.

The Shares will represent 0.14 per cent, of the ordinary share capital of the Company, and are being issued to eight long term investors in the Eastern Minerals Project, who collectively own 4.8 per cent of the Company. Additionally, the Company has issued 1 warrant for every share issued, each with an exercise price of 15.6 pence per share and an exercise period of 3 years (expiring 13 January 2024), in accordance with the terms previously agreed with the holders of the Convertible Bonds, as also set out in the Admission Document.

Application will be made for the admission to trading on AIM ("Admission") for the 247,891 ordinary shares. The ordinary shares will rank pari passu in all respects with the existing ordinary shares of the Company. Admission is expected at 8.00 a.m. on or around 10 February 2021.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 172,436,766 ordinary shares with one voting right each. As the Company does not hold any shares in Treasury, the total number of voting rights in the Company is also 172,436,766 and this figure of ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please visit www.capitalmetals.com or contact:

Capital Metals plc

Michael Frayne (Chief Executive Officer)

+ 44 (0) 20 7317 6800

SPARK Advisory Partners (Nominated Adviser)

Neil Baldwin

+44 (0) 20 3368 3554

Brandon Hill Capital Limited (Broker)

Jonathan Evans/Oliver Stansfield

+44 (0) 20 3463 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSAFWLEFSEIE
Date   Source Headline
17th Jun 20267:00 amRNS-RSri Lanka Mineral Sands Conference
15th Jun 20268:54 amRNSIssue of Equity/Options Grant/TVR
12th Mar 20269:14 amRNSIssue of Equity & Total Voting Rights
12th Mar 20269:14 amRNSIssue of Equity & Total Voting Rights
2nd Mar 20267:00 amRNSProject Updates & Notice of Investor Webinar
11th Feb 20269:06 amRNSPublication of New National Minerals Policy
6th Feb 20267:00 amRNSHolding in Company & Directorate Change
28th Jan 20267:00 amRNSHolding in Company
19th Jan 202611:29 amRNSIssue of Equity & Total Voting Rights
18th Dec 20257:00 amRNSHalf-year Report
10th Dec 202511:30 amRNSCyclone Ditwah - Update on Sri Lanka Operations
17th Nov 20252:17 pmRNS-RNotice of Investor Webcast
17th Nov 20257:00 amRNSMineral Resource Upgrade
6th Nov 20257:00 amRNS-RIndustry Conference Presentation
14th Oct 20252:26 pmRNSIssue of Equity and Warrants; Total Voting Rights
1st Oct 20259:15 amRNSHolding(s) in Company
23rd Sep 20251:56 pmRNSResult of Annual General Meeting
22nd Sep 20257:00 amRNS-RNotice of Investor Webcast & Updated Presentation
18th Sep 20257:36 amRNSProject Updates
15th Sep 20257:00 amRNS3rd Batch of Drill Assay Results
12th Sep 202512:07 pmRNSHolding(s) in Company
12th Sep 202512:01 pmRNSHolding(s) in Company
12th Sep 202511:53 amRNSHolding(s) in Company
12th Sep 202510:53 amRNSHolding(s) in Company
12th Sep 202510:49 amRNSHolding(s) in Company
11th Sep 202512:31 pmRNSHolding(s) in Company
9th Sep 202512:29 pmRNSHolding(s) in Company
5th Sep 20251:31 pmRNSHolding(s) in Company
4th Sep 20257:16 amRNSSheffield Subscription/Grant of Options
2nd Sep 20252:52 pmRNSHolding(s) in Company
2nd Sep 202511:00 amRNSFull Exercise of Ambeon Option and TVR
29th Aug 20254:00 pmRNSNotice of Annual General Meeting
20th Aug 20257:00 amRNSChange of Reg. Office; CFO & CoSec Appointment
19th Aug 20257:57 amRNSFurther Extension of Ambeon Option Period
18th Aug 20257:00 amRNSFinal Results
12th Aug 20254:31 pmRNSExtension of Ambeon Option Period
5th Aug 20257:00 amRNSFirst Tranche of Ambeon Option Exercised
4th Aug 20257:53 amRNSAppointment of Non-Executive Directors
29th Jul 20257:00 amRNSAppointment of Nominated Adviser
28th Jul 20257:14 amRNS2nd Batch of Drill Assay Results
16th Jul 20259:00 amRNSAmbeon Option Extension, Share Options Grant & TVR
16th Jul 20258:46 amRNSInitial Drill Assay Results
13th Jun 20257:00 amRNSRem. Plan, Issue of Equity, Director Shareholding
11th Jun 20257:00 amRNSDrilling Update
2nd Jun 20257:00 amRNSResult of WRAP Retail Offer, Issue of Equity & TVR
30th May 20251:41 pmRNSClose of WRAP Retail Offer
29th May 202511:11 amRNS-RInitiation of Research by Hannam & Partners
29th May 20257:16 amRNSWRAP Retail Offer for up to £300,000
29th May 20257:00 amRNSStrategic Investment & Project Development MoU
2nd Apr 20251:07 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.